Huntington National Bank Biogen Inc. Transaction History

Huntington National Bank

  • $13.4 Billion
  • Q1 2025

A detailed history of Huntington National Bank transactions in Biogen Inc. stock. As of the latest transaction made, Huntington National Bank holds 2,433 shares of BIIB stock, worth $316,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,433
Previous 2,414 0.79%
Holding current value
$316,606
Previous $369,000 10.03%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$133.43 - $153.27 $2,535 - $2,912
19 Added 0.79%
2,433 $332,000
Q4 2024

Feb 12, 2025
BUY
$146.47 - $191.55 $15,525 - $20,304
106 Added 4.59%
2,414 $369,000
Q3 2024

Nov 06, 2024
BUY
$189.07 - $236.8 $14,936 - $18,707
79 Added 3.54%
2,308 $447,000
Q2 2024

Aug 08, 2024
BUY
$190.52 - $236.72 $9,907 - $12,309
52 Added 2.39%
2,229 $516,000
Q1 2024

May 03, 2024
SELL
$212.02 - $267.71 $26,714 - $33,731
-126 Reduced 5.47%
2,177 $469,000
Q4 2023

Feb 07, 2024
SELL
$222.59 - $267.94 $71,006 - $85,472
-319 Reduced 12.17%
2,303 $595,000
Q3 2023

Nov 08, 2023
SELL
$253.3 - $285.89 $1,519 - $1,715
-6 Reduced 0.23%
2,622 $673,000
Q2 2023

Aug 11, 2023
BUY
$275.25 - $318.06 $37,158 - $42,938
135 Added 5.42%
2,628 $748,000
Q1 2023

May 10, 2023
BUY
$256.56 - $292.34 $6,157 - $7,016
24 Added 0.97%
2,493 $693,000
Q4 2022

Feb 09, 2023
SELL
$252.44 - $306.72 $385,475 - $468,361
-1,527 Reduced 38.21%
2,469 $683,000
Q3 2022

Nov 07, 2022
SELL
$194.69 - $268.46 $30,566 - $42,148
-157 Reduced 3.78%
3,996 $1.07 Million
Q2 2022

Aug 09, 2022
BUY
$187.54 - $223.02 $286,936 - $341,220
1,530 Added 58.33%
4,153 $847,000
Q1 2022

May 10, 2022
BUY
$193.77 - $244.14 $968 - $1,220
5 Added 0.19%
2,623 $552,000
Q4 2021

Jan 21, 2022
SELL
$223.92 - $287.77 $36,051 - $46,330
-161 Reduced 5.79%
2,618 $628,000
Q3 2021

Oct 28, 2021
SELL
$282.99 - $369.05 $5,942 - $7,750
-21 Reduced 0.75%
2,779 $787,000
Q2 2021

Jul 30, 2021
BUY
$259.0 - $414.71 $341,621 - $547,002
1,319 Added 89.06%
2,800 $970,000
Q1 2021

Apr 12, 2021
BUY
$242.95 - $284.63 $14,819 - $17,362
61 Added 4.3%
1,481 $414,000
Q4 2020

Jan 11, 2021
SELL
$236.26 - $355.63 $1,417 - $2,133
-6 Reduced 0.42%
1,420 $348,000
Q3 2020

Oct 30, 2020
SELL
$264.77 - $305.71 $5,824 - $6,725
-22 Reduced 1.52%
1,426 $405,000
Q2 2020

Jul 30, 2020
SELL
$258.66 - $342.55 $75,528 - $100,024
-292 Reduced 16.78%
1,448 $388,000
Q1 2020

Apr 27, 2020
SELL
$268.85 - $341.04 $41,402 - $52,520
-154 Reduced 8.13%
1,740 $551,000
Q4 2019

Jan 17, 2020
BUY
$220.06 - $304.07 $35,869 - $49,563
163 Added 9.42%
1,894 $562,000
Q3 2019

Nov 01, 2019
SELL
$217.44 - $243.88 $88,715 - $99,503
-408 Reduced 19.07%
1,731 $403,000
Q2 2019

Jul 23, 2019
SELL
$219.29 - $241.72 $53,726 - $59,221
-245 Reduced 10.28%
2,139 $500,000
Q1 2019

Apr 09, 2019
SELL
$216.71 - $338.96 $17,336 - $27,116
-80 Reduced 3.25%
2,384 $563,000
Q4 2018

Jan 28, 2019
SELL
$278.5 - $352.75 $88,006 - $111,469
-316 Reduced 11.37%
2,464 $741,000
Q3 2018

Oct 18, 2018
BUY
$293.51 - $383.83 $110,359 - $144,320
376 Added 15.64%
2,780 $982,000
Q2 2018

Jul 19, 2018
SELL
$257.52 - $306.91 $19,571 - $23,325
-76 Reduced 3.06%
2,404 $698,000
Q1 2018

Apr 30, 2018
SELL
$260.13 - $367.91 $40,580 - $57,393
-156 Reduced 5.92%
2,480 $679,000
Q4 2017

Feb 02, 2018
SELL
$307.64 - $344.58 $19,381 - $21,708
-63 Reduced 2.33%
2,636 $840,000
Q3 2017

Oct 24, 2017
BUY
$281.15 - $329.69 $758,823 - $889,833
2,699
2,699 $845,000

Others Institutions Holding BIIB

# of Institutions
1,028
Shares Held
127M
Call Options Held
2.29M
Put Options Held
4.26M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $18.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email